Literature DB >> 3489865

Electrical treatment of Lewis lung carcinoma in mice.

A A Marino, D Morris, T Arnold.   

Abstract

Direct electrical current of sufficient magnitude and duration can destroy tissue. This capability may be clinically useful in some cases involving inoperable metastatic lesions. In principle, a tumor could be treated with direct current administered via a percutaneous electrode insulated along its entire length except for the portion actually inserted into the tumor. An animal model was developed to study the effect of direct electrical current on tumor growth. The growth of implanted Lewis lung carcinoma in mice was inhibited following the administration of 2 mA for 1 hr, 1-3 treatments. The effect occurred in both small and large tumors. The results suggest that the electrical technique is potentially useful for treating some tumors.

Entities:  

Mesh:

Year:  1986        PMID: 3489865     DOI: 10.1016/0022-4804(86)90025-9

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  5 in total

Review 1.  Modified cell proliferation due to electrical currents.

Authors:  L Vodovnik; D Miklavcic; G Sersa
Journal:  Med Biol Eng Comput       Date:  1992-07       Impact factor: 2.602

2.  Examination of electric field effects on tissues by using back propagation neural network.

Authors:  Göknur Güler; Firat Hardalaç; Aysel Aricioğlu
Journal:  J Med Syst       Date:  2005-12       Impact factor: 4.460

3.  The effects of low-level direct current therapy on a preclinical mammary carcinoma: tumour regression and systemic biochemical sequelae.

Authors:  D T Griffin; N J Dodd; J V Moore; B R Pullan; T V Taylor
Journal:  Br J Cancer       Date:  1994-05       Impact factor: 7.640

Review 4.  Electrical Stimulation for Immune Modulation in Cancer Treatments.

Authors:  Ritopa Das; Sofia Langou; Thinh T Le; Pooja Prasad; Feng Lin; Thanh D Nguyen
Journal:  Front Bioeng Biotechnol       Date:  2022-01-11

5.  Low-level direct electrical current therapy for hepatic metastases. I. Preclinical studies on normal liver.

Authors:  D T Griffin; N J Dodd; S Zhao; B R Pullan; J V Moore
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.